Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Hancock Jaffe Laboratories (HJLI) stock

Learn how to easily invest in Hancock Jaffe Laboratories stock.

Hancock Jaffe Laboratories, Inc
NASDAQ: HJLI - USD
MEDICAL DEVICES
$6.27
+$0.10 (+1.62%)

Hancock Jaffe Laboratories, Inc is a medical devices business based in the US. Hancock Jaffe Laboratories shares (HJLI) are listed on the NASDAQ and all prices are listed in US Dollars. Hancock Jaffe Laboratories employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Hancock Jaffe Laboratories

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HJLI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Hancock Jaffe Laboratories stock price (NASDAQ: HJLI)

Use our graph to track the performance of HJLI stocks over time.

Hancock Jaffe Laboratories shares at a glance

Information last updated 2021-07-23.
Latest market close$5.91
52-week range$4.99 - $15.00
50-day moving average $6.27
200-day moving average $6.94
Wall St. target price$26.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.54

Buy Hancock Jaffe Laboratories shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Hancock Jaffe Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hancock Jaffe Laboratories price performance over time

Historical closes compared with the close of $5.91 from 2021-05-28

1 week (2021-07-16) N/A
1 month (2021-06-25) -12.31%
3 months (2021-04-27) -9.49%
6 months (2021-01-23) N/A
1 year (2020-07-23) N/A
2 years (2019-07-23) N/A
3 years (2018-07-23) N/A
5 years (2016-07-23) N/A

Hancock Jaffe Laboratories financials

Gross profit TTM $-4,252,249
Return on assets TTM -27.27%
Return on equity TTM -50%
Profit margin 0%
Book value $5.06
Market capitalisation $53 million

TTM: trailing 12 months

Shorting Hancock Jaffe Laboratories shares

There are currently 167,766 Hancock Jaffe Laboratories shares held short by investors – that's known as Hancock Jaffe Laboratories's "short interest". This figure is 24.2% up from 135,109 last month.

There are a few different ways that this level of interest in shorting Hancock Jaffe Laboratories shares can be evaluated.

Hancock Jaffe Laboratories's "short interest ratio" (SIR)

Hancock Jaffe Laboratories's "short interest ratio" (SIR) is the quantity of Hancock Jaffe Laboratories shares currently shorted divided by the average quantity of Hancock Jaffe Laboratories shares traded daily (recently around 62833.707865169). Hancock Jaffe Laboratories's SIR currently stands at 2.67. In other words for every 100,000 Hancock Jaffe Laboratories shares traded daily on the market, roughly 2670 shares are currently held short.

However Hancock Jaffe Laboratories's short interest can also be evaluated against the total number of Hancock Jaffe Laboratories shares, or, against the total number of tradable Hancock Jaffe Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Hancock Jaffe Laboratories's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Hancock Jaffe Laboratories shares in existence, roughly 20 shares are currently held short) or 0.0278% of the tradable shares (for every 100,000 tradable Hancock Jaffe Laboratories shares, roughly 28 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Hancock Jaffe Laboratories.

Find out more about how you can short Hancock Jaffe Laboratories stock.

Hancock Jaffe Laboratories share dividends

We're not expecting Hancock Jaffe Laboratories to pay a dividend over the next 12 months.

Have Hancock Jaffe Laboratories's shares ever split?

Hancock Jaffe Laboratories's shares were split on a 1:25 basis on 29 November 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hancock Jaffe Laboratories shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Hancock Jaffe Laboratories shares which in turn could have impacted Hancock Jaffe Laboratories's share price.

Hancock Jaffe Laboratories share price volatility

Over the last 12 months, Hancock Jaffe Laboratories's shares have ranged in value from as little as $4.99 up to $15. A popular way to gauge a stock's volatility is its "beta".

HJLI.US volatility(beta: 1.5)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hancock Jaffe Laboratories's is 1.5028. This would suggest that Hancock Jaffe Laboratories's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Hancock Jaffe Laboratories overview

Hancock Jaffe Laboratories, Inc. , a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA. .

Frequently asked questions

What percentage of Hancock Jaffe Laboratories is owned by insiders or institutions?
Currently 1.227% of Hancock Jaffe Laboratories shares are held by insiders and 14.615% by institutions.
How many people work for Hancock Jaffe Laboratories?
Latest data suggests 19 work at Hancock Jaffe Laboratories.
When does the fiscal year end for Hancock Jaffe Laboratories?
Hancock Jaffe Laboratories's fiscal year ends in December.
Where is Hancock Jaffe Laboratories based?
Hancock Jaffe Laboratories's address is: 70 Doppler, Irvine, CA, United States, 92618
What is Hancock Jaffe Laboratories's ISIN number?
Hancock Jaffe Laboratories's international securities identification number is: US41015N1063
What is Hancock Jaffe Laboratories's CUSIP number?
Hancock Jaffe Laboratories's Committee on Uniform Securities Identification Procedures number is: 41015N106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site